Barclays group CEO completes cancer treatment, is in remission
By Josh White
Date: Friday 03 Mar 2023
(Sharecast News) - Barclays informed its staff on Friday that its chief executive officer, CS Venkatakrishnan, had completed treatment for non-Hodgkin lymphoma.
The FTSE 100 bank published his letter to the group, confirming he was now in remission.
Venkatakrishnan said he began treatment last November, adding that his remission status meant there was no longer evidence of disease.
"Over the coming weeks, I plan to be working more from the office, and ultimately resuming travel," the CEO added.
At 1629 GMT, shares in Barclays were up 0.01% at 171.78p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN